Qorvo, Inc.
Qorvo, Inc. (QRVO) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Qorvo, Inc. (QRVO), covering cash flow, earnings, and balance sheets.
Qorvo, Inc. (QRVO) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Qorvo, Inc. QRVO financial performance.
| Metric | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Revenue | $869.47M | $916.32M | $1.05B | $886.67M |
| Cost of Revenue | $475.73M | $524.90M | $601.20M | $554.37M |
| Gross Profit | $393.74M | $391.42M | $445.31M | $332.30M |
| Gross Profit Ratio | $0.45 | $0.43 | $0.43 | $0.37 |
| R&D Expenses | $179.93M | $179.13M | $201.05M | $187.60M |
| SG&A Expenses | $93.16M | $90.36M | $107.76M | $114.92M |
| Operating Expenses | $357.68M | $338.39M | $435.63M | $327.70M |
| Total Costs & Expenses | $841.25M | $863.29M | $1.04B | $882.07M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $18.66M | $22.59M | $17.09M |
| Depreciation & Amortization | $32.98M | $73.83M | $76.08M | $76.15M |
| EBITDA | $28.22M | $141.38M | $101.18M | $92.52M |
| EBITDA Ratio | $0.03 | $0.15 | $0.10 | $0.10 |
| Operating Income | $28.22M | $53.02M | $9.68M | $4.61M |
| Operating Income Ratio | $0.03 | $0.06 | $0.009 | $0.005 |
| Other Income/Expenses (Net) | -$13.00M | -$4.13M | -$7.17M | -$5.74M |
| Income Before Tax | $15.22M | $48.90M | $2.50M | -$723000.00 |
| Income Before Tax Ratio | $0.02 | $0.05 | $0.002 | -$0.001 |
| Income Tax Expense | -$16.14M | $7.63M | $19.94M | -$1.14M |
| Net Income | $31.36M | $41.27M | -$17.43M | $414000.00 |
| Net Income Ratio | $0.04 | $0.05 | -$0.02 | $0.00 |
| EPS | $0.34 | $0.44 | -$0.18 | $0.004 |
| Diluted EPS | $0.33 | $0.43 | -$0.18 | $0.004 |
| Weighted Avg Shares Outstanding | $94.59M | $94.34M | $94.89M | $95.47M |
| Weighted Avg Shares Outstanding (Diluted) | $95.45M | $95.03M | $94.89M | $96.51M |
Over the past four quarters, Qorvo, Inc. demonstrated steady revenue growth, increasing from $886.67M in Q1 2025 to $869.47M in Q4 2025. Operating income reached $28.22M in Q4 2025, maintaining a consistent 3% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $28.22M, reflecting operational efficiency. Net income dropped to $31.36M, with EPS at $0.34. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan